FDA Issues EUA for Sequencing-Based Covid-19 Diagnostic Test
Illumina’s CovidSeq test is a high-throughput, NGS-based, in vitro diagnostic workflow enabling the detection of SARS-CoV-2.
Read MorePosted by Steve Halasey | Jun 16, 2020 | Covid 19 |
Illumina’s CovidSeq test is a high-throughput, NGS-based, in vitro diagnostic workflow enabling the detection of SARS-CoV-2.
Read MorePosted by Steve Halasey | Jun 16, 2020 | Covid 19 |
The SARS-CoV-2 receptor-binding domain is capable of inducing antibodies that are highly specific to SARS-CoV-2.
Read MorePosted by Steve Halasey | Jun 16, 2020 | Covid 19 |
The high-definition PCR SARS-CoV-2 assay increases test throughput and reduces complexity of interpretation.
Read MorePosted by Laurie Bonner | Jun 12, 2020 | Covid 19 |
The Senator has released a white paper with five recommendations. Feedback is requested by June 26.
Read MorePosted by Laurie Bonner | Jun 11, 2020 | Covid 19 |
The test can detect up to 12 cytokines and growth factors from a single patient sample.
Read More